Interestingly, the combined treatment based on mCelyvir and intratumoural injections of ICOVIR5 was found to act by inhibition of neoplastic growth and induction of CD4+ and CD8+ T cell recruitment to the tumour microenvironment [185]. The gene discussed is CD4; the disease is neoplasm.